Login / Signup
Juan Bautista Blaquier
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 4
Top Topics
Ejection Fraction
Tyrosine Kinase
Wild Type
Advanced Non Small Cell Lung Cancer
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
Journal of chemotherapy (Florence, Italy)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Juan Bautista Blaquier
,
Sandra Ortiz-Cuaran
,
Biagio Ricciuti
,
Laura Mezquita
,
Andrés Felipe Cardona
,
Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Juan Bautista Blaquier
,
Sandra Ortiz-Cuaran
,
Biagio Ricciuti
,
Laura Mezquita
,
Andrés Felipe Cardona
,
Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Juan Bautista Blaquier
,
Sandra Ortiz-Cuaran
,
Biagio Ricciuti
,
Laura Mezquita
,
Andrés Felipe Cardona
,
Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Juan Bautista Blaquier
,
Gonzalo Recondo
Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S.
Journal of chemotherapy (Florence, Italy)
(2022)